{"transactions":[{"id":2175443,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock,$.01 par value","published_at":"2022-08-25T01:00:55.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":36900,"price":2.71,"value":99999.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being amended to correct the transaction code.  The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective February 28, 2022. The purchase was approved by the Company's Board of Directors."}],"balance_after":576690,"source":{"system":"sec-edgar","filing":"0001209191-22-047428","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122047428/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-28"}},{"id":2175440,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2022-08-25T01:00:36.000Z","date":"2022-07-31","kind":"grant","acquired":true,"shares":5000,"price":2.93,"value":14650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being amended to correct the transaction code.  The securities were purchased through the Company's Employee Stock Purchase Plan effective July 31, 2022."}],"balance_after":781690,"source":{"system":"sec-edgar","filing":"0001209191-22-047423","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122047423/doc4a.xml","form_type":"4/A","original_submission_date":"2022-08-01"}},{"id":2175438,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2022-08-25T01:00:16.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":1804,"price":3.17,"value":5718.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being amended to correct the transaction code.  The securities were purchased through the Company's Employee Stock Purchase Plan effective January 31, 2022."}],"balance_after":539790,"source":{"system":"sec-edgar","filing":"0001209191-22-047421","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122047421/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-02"}},{"id":2176447,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2022-08-24T01:00:24.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":15,"price":3.84,"value":57.6,"ownership":{"direct":true},"balance_after":777075,"source":{"system":"sec-edgar","filing":"0001209191-22-047280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122047280/doc4.xml","form_type":"4"}},{"id":2176446,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2022-08-24T01:00:24.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":4600,"price":3.8507,"value":17713.22,"ownership":{"direct":true},"balance_after":777090,"source":{"system":"sec-edgar","filing":"0001209191-22-047280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122047280/doc4.xml","form_type":"4"}},{"id":2199460,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2022-08-01T10:00:24.000Z","date":"2022-07-31","kind":"purchase","acquired":true,"shares":5000,"price":2.93,"value":14650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2022 representing the maximum allowable under the Plan for this period."}],"balance_after":781690,"source":{"system":"sec-edgar","filing":"0001209191-22-043574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122043574/doc4.xml","form_type":"4"}},{"id":2257308,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-05-26T00:00:13.000Z","date":"2022-05-18","kind":"other","acquired":true,"shares":4789,"price":3.19,"value":15276.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This report corrects total amount of securities beneficially owned as no shares were withheld to satisfy the tax liability incident on 5/18/2022 for the vesting of previously reported restricted stock units."}],"balance_after":776690,"source":{"system":"sec-edgar","filing":"0001209191-22-031996","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122031996/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-25"}},{"id":2262556,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-05-21T00:00:47.000Z","date":"2022-05-18","kind":"tax_withholding","acquired":false,"shares":4789,"price":3.19,"value":15276.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units."}],"balance_after":771901,"source":{"system":"sec-edgar","filing":"0001209191-22-031202","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122031202/doc4.xml","form_type":"4"}},{"id":2274042,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Restricted Stock Unit","published_at":"2022-05-13T00:01:13.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock unit will vest on May 10, 2025 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 10, 2022.  The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows:  less than 25th percentile=0% of target,  25th percentile=50% of target,  50th percentile=100% of target,  75th percentile=200% percent of target,  90th percentile or higher=300% maximum.  Payout values will be interpolated between the percentile rankings above."}],"balance_after":776690,"source":{"system":"sec-edgar","filing":"0001209191-22-028679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122028679/doc4.xml","form_type":"4"}},{"id":2274041,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Endocrine Business Unit"}}],"security":"Restricted Stock Unit","published_at":"2022-05-13T00:01:13.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date."}],"balance_after":666690,"source":{"system":"sec-edgar","filing":"0001209191-22-028679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122028679/doc4.xml","form_type":"4"}},{"id":2366901,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock,$.01 par value","published_at":"2022-03-01T22:01:14.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":36900,"price":2.71,"value":99999.0,"ownership":{"direct":true},"balance_after":576690,"source":{"system":"sec-edgar","filing":"0001209191-22-014102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122014102/doc4.xml","form_type":"4"}},{"id":2407013,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2022-02-10T02:00:31.000Z","date":"2022-01-31","kind":"purchase","acquired":true,"shares":1804,"price":3.17,"value":5718.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2022. The amended number of shares purchased were limited by Section 423(b)(8) of the Code."}],"balance_after":539790,"source":{"system":"sec-edgar","filing":"0001209191-22-008268","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122008268/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-02"}},{"id":2418104,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2022-02-02T22:00:45.000Z","date":"2022-01-31","kind":"purchase","acquired":true,"shares":2334,"price":3.17,"value":7398.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective January 31, 2022."}],"balance_after":540320,"source":{"system":"sec-edgar","filing":"0001209191-22-006415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919122006415/doc4.xml","form_type":"4"}},{"id":2588843,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-08-28T01:01:13.000Z","date":"2021-08-27","kind":"tax_withholding","acquired":false,"shares":9616,"price":4.91,"value":47214.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units."}],"balance_after":537986,"source":{"system":"sec-edgar","filing":"0001209191-21-053770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919121053770/doc4.xml","form_type":"4"}},{"id":2620602,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2021-08-03T00:00:22.000Z","date":"2021-07-30","kind":"purchase","acquired":true,"shares":5000,"price":2.99,"value":14950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2021 representing the maximum allowable under the Plan for this period."}],"balance_after":547602,"source":{"system":"sec-edgar","filing":"0001209191-21-049137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919121049137/doc4.xml","form_type":"4"}},{"id":2704033,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-05-20T21:00:16.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":79000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021.  The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows:  less than 25th percentile=0% of target,  25th percentile=50% of target,  50th percentile=100% of target,  75th percentile=200% percent of target,  90th percentile or higher=300% maximum.  Payout values will be interpolated between the percentile rankings above."}],"balance_after":542602,"source":{"system":"sec-edgar","filing":"0001209191-21-034451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919121034451/doc4.xml","form_type":"4"}},{"id":2704032,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-05-20T21:00:16.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date."}],"balance_after":463602,"source":{"system":"sec-edgar","filing":"0001209191-21-034451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919121034451/doc4.xml","form_type":"4"}},{"id":2950728,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2020-12-10T23:57:47.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":34602,"price":2.89,"value":99999.78,"ownership":{"direct":true},"balance_after":398602,"source":{"system":"sec-edgar","filing":"0001209191-20-062790","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919120062790/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-10"}},{"id":2950727,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2020-12-10T22:07:11.000Z","date":"2018-11-14","kind":"purchase","acquired":true,"shares":34602,"price":2.89,"value":99999.78,"ownership":{"direct":true},"balance_after":398602,"source":{"system":"sec-edgar","filing":"0001209191-20-062750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919120062750/doc4.xml","form_type":"4"}},{"id":3044039,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-08-31T23:07:40.000Z","date":"2020-08-27","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020.  The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows:  less than 25th percentile=0% of target,  25th percentile=50% of target,  50th percentile=100% of target,  75th percentile=200% percent of target,  90th percentile or higher=300% maximum.  Payout values will be interpolated between the percentile rankings above."}],"balance_after":364000,"source":{"system":"sec-edgar","filing":"0001209191-20-048847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919120048847/doc4.xml","form_type":"4"}},{"id":3044038,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":124312,"kind":"person","name":"Galindo Alejandro","position":1,"cik":"0001821447","reported_name":"Galindo Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-08-31T23:07:40.000Z","date":"2020-08-27","kind":"grant","acquired":true,"shares":164000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date."}],"balance_after":164000,"source":{"system":"sec-edgar","filing":"0001209191-20-048847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919120048847/doc4.xml","form_type":"4"}}]}